Back to UBS Group AG UBS Group AG

AEMDAEMD
2 quarters

Position history for UBS Group AGUBS Group AG's holdings in AETHLON MED INC

Yes. Ubs holds 8,876 shares of AEMD (Aethlon Med), worth $7,305, as of its Q2 2026 13F filing. It increased the position from 895 shares in Q1 2026. Ubs has held AEMD since Q1 2026, across 2 quarterly 13F filings.

Current Value

$7,305

Current Shares

8,876

Total Value Change

+$5,344

Total Shares Change

+7,981

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
8,876
+891.7%
$7,3050.0%$4.10
18
2026-Q1
New
895
-
$1,9610.0%$10.95
17

Other major holders of AEMD: HRT FINANCIAL LP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, XTX Topco Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used